Single-cell and spatial transcriptome profiling identifies cellular heterogeneity and immunosuppressive tumor microenvironment in inflammatory breast cancer
Open Access
- 1 June 2025
- journal article
- Published by Elsevier in Journal of Advanced Research
- Vol. 81, 637-656
Abstract
No abstract availableKeywords
Funding Information
- Zhejiang Province Natural Science Foundation (LY23H160026)
- Zhejiang Province Natural Science Foundation (LY22H290004)
- National Natural Science Foundation of China (81630080)
This publication has 60 references indexed in Scilit:
- Survival outcomes seen with neoadjuvant chemotherapy in the management of locally advanced inflammatory breast cancer (IBC) versus matched controlsThe Breast, 2023
- Inflammatory breast cancer was misdiagnosed as plasma cell mastitis: A case reportAsian Journal of Surgery, 2022
- Neoantigen-specific CD4+ T cells in human melanoma have diverse differentiation states and correlate with CD8+ T cell, macrophage, and B cell functionCancer Cell, 2022
- Inflammatory breast cancer defined: proposed common diagnostic criteria to guide treatment and researchBreast Cancer Research and Treatment, 2022
- Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancerCancer Cell, 2021
- Incidence and survival of inflammatory breast cancer between 1973 and 2015 in the SEER databaseBreast Cancer Research and Treatment, 2020
- Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid TumorsCancer Cell, 2019
- Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor MicroenvironmentCell, 2018
- IFITM1 suppression blocks proliferation and invasion of aromatase inhibitor-resistant breast cancer in vivo by JAK/STAT-mediated induction of p21Cancer Letters, 2017
- Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 TherapyCell, 2016